Last reviewed · How we verify
Combination of Naproxen and Pregabalin
Combination of Naproxen and Pregabalin is a Small molecule drug developed by Xgene Pharmaceutical Group. It is currently in Phase 1 development.
At a glance
| Generic name | Combination of Naproxen and Pregabalin |
|---|---|
| Sponsor | Xgene Pharmaceutical Group |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Combination of Naproxen and Pregabalin CI brief — competitive landscape report
- Combination of Naproxen and Pregabalin updates RSS · CI watch RSS
- Xgene Pharmaceutical Group portfolio CI
Frequently asked questions about Combination of Naproxen and Pregabalin
What is Combination of Naproxen and Pregabalin?
Combination of Naproxen and Pregabalin is a Small molecule drug developed by Xgene Pharmaceutical Group.
Who makes Combination of Naproxen and Pregabalin?
Combination of Naproxen and Pregabalin is developed by Xgene Pharmaceutical Group (see full Xgene Pharmaceutical Group pipeline at /company/xgene-pharmaceutical-group).
What development phase is Combination of Naproxen and Pregabalin in?
Combination of Naproxen and Pregabalin is in Phase 1.